Overview

Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke

Status:
Terminated
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The study is designed to examine the safety, tolerability, and activity of a combination of microbubbles (perflutren lipid microsphere [Definity®]) and continuous monitoring with 2 MHz transcranial Doppler ultrasound (TCD) as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
ImaRx Therapeutics